PURPOSE. Wound healing of the corneal epithelium is highly influenced by regulation of integrin gene expression. A recent study demonstrated that laminin (LM), a major constituent of the extracellular matrix (ECM), reduces expression of the human ␣6 integrin subunit gene by altering the properties of the transcription factor (TF) Sp1. In this work, a target site was identified for the TF nuclear factor I (NFI) on the human ␣6 gene, and its regulatory influence was characterized in corneal epithelial cells. METHODS. Plasmids bearing the ␣6 promoter fused to the CAT gene were transfected into human (HCECs) and rabbit (RCECs) corneal epithelial cells grown on LM. The DNA-binding site for NFI in the ␣6 promoter was identified by DNase I footprinting. Expression and DNA binding of NFI was monitored by Western blot, RT-PCR, and electrophoretic mobility shift assays (EMSAs), and its function was investigated through RNAi and NFI overexpression assays. RESULTS. All NFI isoforms were found to be expressed in HCECs and RCECs. Transfection analyses revealed that NFI is a repressor of ␣6 expression in both types of cells. LM increases expression of NFI, whereas inhibition of each NFI isoform increases promoter activity suggesting that NFI is a key repressor of ␣6 transcription. In addition, the negative influence of NFI appears to be potentiated by the degradation of Sp1 when cells are grown on LM. CONCLUSIONS. Repression of ␣6 expression therefore contributes to the final steps of corneal wound healing by both reducing proliferation and allowing attachment of the epithelium to the basal membrane. (Invest Ophthalmol Vis Sci.
T he corneal epithelium is composed of well-organized and structured epithelial cells.
1,2 When a wound occurs, the epithelial cells are triggered to restore proper visual acuity. 3, 4 This process is promoted by the extracellular matrix (ECM), which constitutes the basal membrane (BM) of the epithelium. 5, 6 The early events of the wounding process are characterized by massive secretion of fibronectin (FN), which is believed to serve as a temporary matrix for the attachment and migration of the basal epithelial cells that border the injured area. 7 FN levels peak between 3 and 12 hours in the BM after corneal injury and start disappearing 1 week thereafter. 5, 8 As FN staining progressively diminishes, secretion of LM, also a major component of the BM, increases to reach maximum expression 1 week after corneal damage. 5 LM-1 (recently reclassified as LM-111), LM-5 (recently reclassified as LM-332), and LM-10 (recently reclassified as LM-511) 9 are the major LM isoforms present in the corneal BM. 10, 11 Although the primary function of both FN and LM is to ensure cell-matrix attachment, interaction with their corresponding transmembrane integrin receptors also controls cell shape, gene expression, cell migration and proliferation, and programmed cell death.
Integrins function as transmembrane heterodimers consisting of individual ␣ and ␤ chains. They constitute adhesion receptors that link the ECM to the cytoplasm components to mediate the transfer of information through diverse signaling pathways 12, 13 (reviewed in Ref. 14) . In the corneal epithelium, the expression of 12 heterodimers have been reported: ␣1␤1, ␣2␤1, ␣3␤1, ␣4␤1, ␣5␤1, ␣6␤1, ␣6␤4, ␣9␤1, ␣v␤1, ␣v␤3, ␣v␤5, and ␣v␤6 (reviewed in Refs. 15, 16) . The integrin subunit ␣6, which was first described as forming an ␣6␤1 complex, can also partner with the ␤4 integrin subunit. 17, 18 Both the ␣6␤1 and ␣6␤4 integrins have been recognized as LM receptors, but anchorage of the basal corneal epithelial cells to the corneal BM is a process ensured by the ␣6␤4 integrin. 19 -21 Although the involvement of ␣6␤4 in hemidesmosome (HD) organization 17, 22 has dominated the study of this integrin, recent studies have demonstrated its critical role in the migration of epithelial and carcinoma cells, where the primary signaling event triggered by ␣6␤4 appears to be the activation of the PI3-K pathway, which has profound consequences on the migration, invasion, and survival of carcinoma cells. [23] [24] [25] Mice lacking either ␣6 or ␤4 integrins die at birth; their skin separates at the dermal-epidermal junction because of the lack of HD. 26, 27 Patients who carry mutations in ITGA6 or ITGB4 (the genes encoding the ␣6 and ␤4 integrin chains, respectively) also develop epidermolysis bullosa, a severe skin disease. 28, 29 It is now clearly established that the integrin levels fluctuates greatly during corneal wound healing. Such fluctuations as occur during cell cycle progression are mediated by transcription factors (TFs) that bind the promoters of these integrin's genes to regulate their transcription. 16, 30 Many TFs have been reported specifically to regulate integrin's gene expression during corneal wound healing, such as Pax6, Sp1, and Sp3 for the integrins subunit ␣4, ␣5, and ␣6. [31] [32] [33] [34] NFI is of particular interest in that target sites for this TF have been shown to be present on the promoter of many integrin genes, including ␣6 31 (see Ref. 16 for complete review of all known TFs on integrin's regulation), although none of them has been fully characterized. The NFI family includes four genes in vertebrates: NFIA, -B, -C, and -X. The mRNA transcript of each NFI gene can be differentially spliced and may encode NFI proteins that differ in their ability to either activate or repress transcription by interacting with other cofactors via their C-terminal catalytic domain. [35] [36] [37] [38] The first 200 amino acids from the Nterminal region of NFI are rigorously conserved in all four isoforms and act as a DNA-binding domain that can bind the 5Ј-TGGA/C(N) 5 GCCAA-3Ј consensus element often located in close proximity of binding sites for other transcription factors in gene promoter regulatory regions. 39 -42 In a previous study, we investigated the positive regulatory influence exerted by the TFs Sp1 and Sp3 on the transcriptional regulation of the ␣6 gene. 31 The ␣6 promoter was found to be downregulated when RCECs were grown on LM-coated culture plates. The reduced ␣6 promoter activity was shown to rely at least in part on a reduced level of expression of both Sp1 and Sp3 in corneal epithelial cells (both rabbit corneal epithelial cells [RCECs] and human corneal epithelial cells [HCECs] ) when grown on LM. Because a potential NFI consensus binding sequence was identified close to the promoter proximal Sp1 site from the human ␣6 gene and that NFI has been reported to compete against Sp1, 43, 44 we investigated further whether NFI also contributes to the LM-mediated downregulation of the ␣6 gene. In the present study, we found evidence that NFI binds to the ␣6 promoter and represses its activity in corneal epithelial cells. This repressive influence of NFI was found to be potentiated by LM in HCECs but not RCECs. Most of all, NFI repressed ␣6 transcription without competing with Sp1, as both proteins were capable of interacting simultaneously with their respective target sites in the basal promoter from the ␣6 gene. NFI may therefore contribute to the ␣6-mediated growth arrest of the basal epithelial cells when LM is present during the final steps of the corneal wound-healing process.
METHODS
All experiments described in this article were conducted in voluntary compliance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research, and all procedures were approved by the Laval University Animal Care and Use Committee. The study was also conducted in accordance with our institution's guidelines and the Declaration of Helsinki. The protocols were approved by the institution's Committee for the Protection of Human Subjects.
Cell Culture and Media
HCECs were isolated from the limbal area of normal eyes from donors 44, 62, 64, and 78 years of age, obtained through the Eye Bank from the CHUL (Centre Hospitalier Universitaire Laval) Research Center, according to a procedure previously described. 30, 45 RCECs were obtained from the central area of freshly dissected rabbit corneas and grown into supplemented SHEM, as recently described. 31, 46 Laminin-coating of tissue culture plates has been detailed elsewhere.
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Plasmids and Oligonucleotides
The recombinant plasmid bearing the ␣6 promoter sequence from Ϫ181 to ϩ76 bp relative to the transcription initiation start (TIS) site fused to the CAT reporter gene (referred as ␣6-181) was constructed as previously described. 31 The ␣6-181/mSp1p recombinant construct that bears mutations in the promoter proximal Sp1 site has been described previously.
31
The double-stranded oligonucleotides used for the competition assays in the EMSAs contained the following DNA sequences: The high-affinity binding sites for the TFs NFI (NFI; 5Ј-TTATTTTGGATT-GAAGCCAATATGAG-3Ј) 47 and Sp1 (5Ј-GATCATATCTGCGGGGCG-GGGCAGACACAG-3Ј) 48 ; the NFI site from the ␣6 promoter (from position Ϫ37 to ϩ3) (␣6NFI; 5Ј-CGTCCTCGTCACTTGATAAAACGC-CTGCGAGTCTCCAGAG-3Ј).
DNase I Footprinting
DNase I footprinting was performed as described previously, 31 with increasing amounts of a carboxymethyl (CM)-Sepharose-enriched preparation of rat liver NFI. 49 The probe used for the assay consisted of a 257-bp HindIII/XbaI DNA fragment (and digested from the recombinant plasmid ␣6-181 31 ) spanning the ␣6 promoter sequence from positions Ϫ181 to ϩ76 and 5Ј end labeled at its XbaI site.
Transient Transfections and CAT Assays
Both HCECs and RCECs were grown to near confluence (80% coverage of the culture plate) into six-well (35 mm) tissue culture plates and transiently transfected using polycationic detergent (Lipofectamine; Invitrogen-Gibco, Grand Island, NY) according to a procedure we previously described. 31 Each transfected plate received 1 g of the ␣6-CAT test plasmid and 0.5 g of the human growth hormone (hGH) encoding plasmid pXGH5. Levels of CAT activity for all transfected cells were determined and normalized to the amount of hGH secreted into the culture medium and assayed using a kit for quantitative measurement of hGH (Immunocorp, Montréal, Québec, Canada). The value presented for each test plasmid transfected corresponds to the mean of at least three separate transfections performed in triplicate. To be considered significant, each value had to be at least three times over the background level caused by the reaction buffer used (usually corresponding to 0.15% chloramphenicol conversion). Student's t-test was performed for comparison of the groups. Differences were considered to be statically significant at P Ͻ 0.05. All data are expressed as the mean Ϯ SD. The pCH NFI constructs were kindly provided by Richard M. Gronostajski (Case Western Reserve University, Cleveland, OH). cells per dish at start) by lipofection (Lipofectamine; InvitrogenGibco), along with 1 g of the plasmid construct ␣6-181. The cells were harvested 24 hours after the addition of fresh medium and processed as mentioned earlier for the CAT assay.
RNAi Assays
38
Nuclear Extracts, EMSAs, and SDS-PAGE/Western Blot
Crude nuclear extracts were prepared and EMSAs conducted as detailed previously. 9, 31, 33 Briefly, EMSAs were conducted by incubating either crude nuclear extracts (5 g) or CM-Sepharose-enriched NFI (either 0.5 or 1 L) 50 in the presence of either the high-affinity NFI or the ␣6NFI oligomer as labeled probes. For the co-binding experiment, both the enriched NFI and a recombinant preparation of Sp1 (GSTSp1-8xHis protein; kindly provided by Claude Labrie, Oncology and Molecular Endocrinology Research Center, CHUL Research Center) 51 were used either individually or in combination. When indicated, unlabeled oligomers were added as competitors (100-and 250-fold molar excesses). DNA-protein complexes were then separated by gel electrophoresis through 10% native polyacrylamide gels run against Tris-glycine buffer. 52 Supershift experiments were conducted by incubating 5 g nuclear proteins from RCECs in the presence of 200 ng, 500 ng, or no polyclonal antibodies raised against NFI (SC-5567) or Sp1 (SC-59; Santa Cruz Biotechnology, Inc., Santa Cruz, CA). SDS-PAGE and Western blot protocols have been described elsewhere.
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Semiquantitative RT-PCR
Total RNA was isolated with the (RNA Easy Kit) according to the manufacturer's protocol (Molecular Research Center Inc., Cincinnati, OH) from HCECs grown on BSA or LM-coated culture plates or from HCECs transfected with the siRNA (as a control; Silencer; Ambion), the Sp1 siRNA, or a combination of the NFIB, -C and -X siRNAs. Ten micrograms of each RNA sample was then used to create cDNAs (Superscript II Transcriptase kit; Invitrogen-Gibco) and was purified as recently detailed. 31, 32 PCR, visualization, and analysis were conducted with DNA polymerase (Platinum Taq; [Invitrogen, Carlsbad, CA]), as previously detailed. 31 The following primer sets were used: ␣6 (PCR product of 210 bp) forward 5Ј-CAAGATGGCTACCCAGATAT-3Ј and reverse 5Ј-CT-GAATCTGAGAGGGAACCA-3Ј; glyceraldehyde-3-phosphate (GAPDH; PCR product of 220 bp) forward 5Ј-ATGCAACGGATTTGGTCGTAT-3Ј and reverse 5Ј-TCTCGCTCCTGGAAGATGGTG-3Ј 53 ; ␤-actin (ACTB; PCR product of 494 bp) forward 5Ј-CCTGGACTTCGAGCAAGAGAG-3Ј
and reverse 5Ј-CTAACGCAACTAAGTCATAGTCCG-3Ј 54 ; ␤-2-microglobulin (B2M, PCR product 86 bp) forward 5Ј-TGCTGTCTCCATGTT-TGATGTATCT-3Ј and reverse 5Ј-TCTCTGCTCCCCACCTCTAAGT-3Ј 55 ; NFIA (PCR product of 300 bp) forward 5Ј-ACGCTGAAAGAATTTGTC-CAACT-3Ј and reverse 5Ј-GGGGTCAGGTGGTCTGTCT-3Ј; NFIB (PCR product of 149 bp) forward 5Ј-TATTCGCCAGGAGTATCGAGAG-3Ј and reverse 5Ј-CTAGATCCAGACGCCAGACTT-3Ј; NFIC (PCR product of 205 bp) forward 5Ј-TACCTGGCCTACTTCGTGC-3Ј and reverse 5Ј-AGTTGGGTCCTGTTCCAGTCA-3Ј; NFIX (PCR product of 275 bp) forward 5Ј-GAAGCCCGAGATCAAGCAGAA-3Ј and reverse 5Ј-GAGGC-GACTTGTAGAGCCG-3Ј; and Sp1 (PCR product of 241 bp) forward 5Ј-ATTGAGTCACCCAATGAGAACAG and reverse 5Ј-CAGCCACAA-CATACTGCCC-3Ј. To ensure that PCR saturation was not reached, we performed 23, 25, 27, 29, 31, and 34 cycles.
RESULTS
In Vitro Footprinting of the NFI Binding Site on the ␣6 Promoter
As previous works conducted in our laboratory using chromatin immunoprecipitation (ChIP) assays showed evidence of the binding of NFI to the ␣6 promoter in HCECs cultured either on BSA-or LM-coated culture plates, 31 we conducted DNase I footprinting on this area to locate the NFI site precisely. A 257-bp 5Ј end-labeled DNA fragment spanning the entire ␣6 basal promoter from position Ϫ181 to ϩ76 was incubated with increasing amounts of a CM-Sepharose-enriched preparation of rat liver NFI. A single target site for NFI was identified along the ␣6 promoter sequence, between positions Ϫ32 and Ϫ1 relative to the TIS (Figs. 1A, 1B). Although it did not exactly match the known consensus NFI binding sequence, the formation of a DNase I-protected site was a clear indication that NFI interacted directly with this area of the ␣6 promoter (Fig. 1B) . A labeled probe bearing the ␣6 promoter from positions Ϫ181 to ϩ76 was incubated with 2.5 and 10 g nuclear proteins from a CM-Sepharose-enriched preparation of rat liver NFI and subjected to DNase I digestion. The position of the NFI protected site (NFI) is indicated. G, Maxam and Gilbert G sequencing ladder; C, labeled probe subjected to DNase I digestion but without nuclear proteins. (B) Positioning of both the footprinted NFI site and the Sp1 proximal (Sp1p) target site along the ␣6 promoter relative to the TIS (ϩ1).
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Effect of Laminin on the Transcription of the NFI Genes
To determine which of the four NFI proteins (A, B, C, or X) are expressed in HCECs and RCECs and whether LM alters their expression, we conducted semiquantitative RT-PCR analyses. PCR amplification of all products remained linear from 23 to 29 cycles of amplification (data not shown). RT-PCR analysis showed that all NFI isoforms were transcribed in HCECs grown on BSA (ϪLM; two primary cultures were used: HCEC44 and HCEC62, isolated from the eyes of 44-and 62-year-old donors, respectively; Fig. 2A ). However, substantial variations in mRNA levels were observed relative to the level observed for the housekeeping genes that are used for normalization of the data (for instance, GAPDH, ACTB, and B2M 55 ), when both cell lines were grown on LM-coated culture plates. Indeed, NFIA mRNA increased considerably, whereas expression of NFIC decreased when HCECs were grown on LM. However, expression of both NFIB and NFIX remained unchanged under this culture condition. As previously reported, mRNA levels for both the ␣6 and Sp1 transcripts were markedly decreased in the presence of LM. Identical results (increased expression of NFIA and decreased expression of both NFIC and ␣6) were also observed in RCECs (Fig. 2B ).
Effect of LM on Expression and DNA Binding of NFI
Because of the difficulty in obtaining the human corneas from which HCECs are cultured, and as the LM-dependent changes in the expression of the NFI mRNA transcripts were the same between HCECs and RCECs, we performed the subsequent analyses with RCECs. To determine whether the changes in NFI mRNA expression would also translate into corresponding alterations in the amount of NFI proteins, Western blot analyses were first conducted using nuclear extracts from RCECs that have been grown either on BSA-or on LM-coated culture plates. With a polyclonal Ab directed against the N-terminal DNA-binding domain shared by all four NFI isoforms (i.e., it indiscriminately recognizes all four NFI proteins), we noted an important increase in the amount of a slow-migrating NFI isoform (Fig. 3A, ϩ) whereas other, faster migrating isoforms disappeared (Fig. 3A, Ϫ) when cells were grown in the presence of LM (ϩLM; Fig. 3A) . As expected from previous work, 31 we noted the reduced expression of Sp1 under the same conditions, in control experiments. We then examined the binding capability of NFI by EMSA using a double-stranded oligonucleotide bearing a high-affinity binding site for NFI as the labeled probe. Binding of NFI substantially increased in the presence of LM in comparison to NFI derived from nuclear extracts of RCECs grown on BSA (Fig. 3B , compare lane 3 with lane 2 and lane 10 with lane 9). Of interest, the DNA-protein complex yielded by the LM-derived extract had a slightly faster migration pattern suggesting that, when cells are grown in the presence of LM (ϩLM), this NFI isoform may be subjected to posttranslational modifications that are different from those in cells grown on BSA (ϪLM). The identity of the NFI complex was further validated by EMSAs, as addition of a polyclonal Ab directed against NFI almost entirely supershifted (SC on Fig.  3B ) the NFI DNA-protein complex on the gel (ϪLM: lanes 4 and 5; ϩLM: lanes 11 and 12). Furthermore, only the oligonucleotide bearing the high-affinity binding site for NFI (ϪLM: lanes 6 and 7; ϩLM: lanes 13 and 14), but not that for Sp1 (ϪLM: lane 8; ϩLM: lane 15), could compete for the formation of the NFI complex, therefore establishing that the DNAprotein complex seen on the gel indeed corresponds to the recognition of the labeled probe by NFI. Incubation of the same protein extracts with the Sp1-labeled probe resulted in a reduced formation of both the typical Sp1/Sp3 DNA-protein complexes when cells were grown on LM (Fig. 3C, lane 3) , a result consistent with the reduced Sp1 level observed in Western blot analysis (Fig. 3A) .
EMSAs were then conducted by substituting the labeled probe bearing the consensus NFI site with a similar oligomer bearing the DNA sequence of the NFI site footprinted on Figure 1 along the ␣6 promoter (␣6NFI) using the same RCEC extracts grown with (ϩLM) or without (ϪLM) LM (Fig. 4 ). An NFI complex of weak intensity was detected with the protein extract from RCECs grown without LM (lane 2). However, formation of this DNA-protein complex markedly increased in the nuclear extract from cells grown on LM (lane 3). Formation of this complex was almost entirely prevented by the addition of a 100-fold molar excess of the oligomer bearing the consensus sequence for NFI (lane 4) but not by the Sp1 oligomer (lane 5), thereby establishing the specificity for the formation of this complex. The identity of NFI as being the protein component of the DNA-protein complex observed in Figure 4B was further demonstrated by supershift analyses. Indeed, the addition of the NFI Ab to the reaction mixture reduced formation of the fast-migrating complex (NFI) and resulted in the formation of a new complex (SC) with a lower electrophoretic mobility that resulted from the binding of the Ab to the NFI protein component from the NFI/␣6NFI complex (lane 6).
The NFI target site from the ␣6 promoter differs from the prototypical sequence by two nucleotides over the entire 15 bp that constitute this site (Fig. 4A) . However, and based on the binding site predictor algorithm developed by Roulet et al., 41 NFI was expected to bind the ␣6 NFI site with an affinity near 57%. To assess the affinity of NFI toward both the ␣6 and the prototypical NFI target sites, we incubated a CM-Sepharose-enriched preparation of NFI with the high-affinity NFI binding site labeled probe in the presence of various concentrations (50-to 800-fold molar excesses) of either an unlabeled DNA fragment from the ␣6 promoter (positions Ϫ84 to ϩ76), which also bears the NFI site footprinted in Figure 1 (␣6-84/ ϩ76) or the NFI oligomer. As shown in Figure 4C , the unlabeled ␣6-84/ϩ76 fragment was almost as efficient as the prototypical NFI-bearing oligonucleotide in competing for the formation of the NFI complex in EMSA. Densitometric measurement of the band intensities indicated that the affinity of NFI toward the ␣6 NFI site contained on the ␣6-84/ϩ76 was approximately 80% of that obtained for the prototypical NFI site. This result provided evidence that NFI binds to the ␣6-degenerated NFI site with an affinity very near that obtained with the prototypical NFI site. We therefore conclude that NFI possesses the ability to bind the NFI site from the ␣6 promoter efficiently and that both its expression and DNA-binding properties can be modulated by the presence of LM.
Sp1 and NFI Binding to the ␣6 Basal Promoter In Vitro
Because the NFI site identified in this study is located near the promoter proximal Sp1 site, we then examined whether both transcription factors can interact simultaneously with their respective target site or whether they compete with each other for the availability of their DNA-binding site in the ␣6 promoter. For that purpose, EMSAs were conducted with the 160-bp DNA fragment covering the entire ␣6 promoter from position Ϫ84 to ϩ76 (␣6-84/ϩ76) used as the labeled probe, therefore including both the NFI and proximal Sp1 sites. As Figure 5 indicates, incubating the ␣6-84/ϩ76 labeled probe with either Sp1 (lanes 2 and 3) or NFI (lanes 4 and 5) yielded A. 3 to 7) or of a DNA fragment from the ␣6 promoter that also bears the NFI site footprinted in Figure 1 (␣6-84/ϩ76; lanes 8 -12) . The unlabeled Sp1 oligonucleotide (800-fold excess) was also used as a negative control in this competition experiment (lane 13). 
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RNAi Suppression of NFI on ␣6 Gene Expression
Evidence that NFI functionally represses ␣6 promoter activity was further examined through the suppression of the endogenous NFI transcripts by RNAi (Fig. 6) . The recombinant construct ␣6-181 was cotransfected with a pool of siRNAs directed against NFIA, -B, -C, and -X, as well as against Sp1 which has been used as a control in these experiments. Cotransfection with NFIB, -C, and -X siRNAs considerably released repression over the ␣6 promoter construct (2.7ϫ, 2.4ϫ, and 1.7ϫ increase, respectively), suggesting that all three isoforms function as transcriptional repressors of ␣6 gene expression. Of note, cotransfection with the NFIA siRNAs had no noticeable effect, therefore suggesting that either NFIA is not a repressor of ␣6 or that its nuclear concentration is much too low in HCECs to have any influence on the transcription of the ␣6 gene. Silencing Sp1 by RNAi decreased the expression of the ␣6 promoter by approximately 32%, further supporting a role for Sp1 as a transcriptional activator of ␣6 gene expression. As promoter analyses may occasionally differ from those conducted on the endogenous transcript, we therefore examined whether silencing NFI would cause the same effect on the expression of the ␣6 gene from HCECs. As shown on Figure  6B , silencing NFIB, -C, and -X simultaneously in HCECs through RNAi considerably increased the expression of the endogenous ␣6 gene, whereas silencing Sp1 entirely abolished it. The efficiency of NFI and Sp1 siRNA knockdown was also investigated by monitoring the DNA-binding capability for their corresponding consensus sequence by EMSAs (Fig. 6C) . As expected, DNA binding of both NFI (lane 3) and Sp1 (lane 7) was severely reduced in cells transfected with the NFI and Sp1 siRNAs, respectively. This effect was highly specific, as binding of NFI remained unaffected by the Sp1 siRNAs (lane 4) as that of Sp1 toward the NFI siRNAs (lane 8).
Influence of NFI Overexpression ␣6 Gene Transcription
To examine further the negative regulatory influence of NFI on the ␣6 promoter, the ␣6-181 recombinant construct was cotransfected along with expression plasmids encoding high levels of each of the NFI isoforms into HCECs or RCECs grown either on BSA or on LM. Transfections revealed that all four NFI isoforms could strongly repress (ranging from 3-to 15-fold repression) the activity directed by the ␣6-181 construct when compared with cells transfected with an empty vector (ϩEV) as a control (Fig. 7A, filled columns) , irrespective of whether cells were of human (HCECs; Fig. 7A ) or rabbit (RCECs; Fig.  7A ) origin. These results also confirmed that NFIA acts as a repressor of ␣6 transcription and therefore suggest that the lack of any regulatory influence observed with the NFIA siRNAs (Fig. 6A) is probably the consequence of low levels of expression of this isoform in HCECs or that NFIA possesses a much lower DNA-binding capability than does the remaining NFI isoforms toward the NFI site from the ␣6 promoter. A dramatic repression in the basal activity directed by the ␣6 promoter was also observed when HCECs were grown on LM-coated culture plates in the absence of NFI expression plasmids (which dropped by 11-fold on LM-coated culture plates; Fig. 7A, ϩEV) . This drop in the ␣6 promoter activity is consistent with the substantial increase in the expression and DNA binding of NFI combined to the reduced expression of Sp1 observed above in Western blot and EMSA analyses when cells are grown on LM. Overexpression of the NFI isoforms in HCECs grown on LM (Fig. 7A , gray columns) resulted in a further repression in the activity directed by the ␣6-181 construct, suggesting that the ␣6 promoter was not yet saturated in vivo by naturally occurring NFI levels, which would allow for some residual Sp1 activity under the presence of a high repressive environment. Very much the same results were obtained in the RCECs (Fig. 7A) , although the negative influence of LM was clearly less pronounced than in the HCECs. We then transfected RCECs that had been grown either on BSA or LM with the ␣6-181 construct or its derivative, which carries the mutation into the proximal Sp1 site. As expected, mutating the proximal Sp1 binding site resulted in a much more reduced expression directed by the ␣6 promoter (Fig.  7B, ϩEV, gray columns) . Most interesting, overexpression of the NFI isoforms in the background of the ␣6-181/mSp1p mutated construct led to much stronger repression of the ␣6 promoter (30-, 20-, 16-, and 10-fold repression with NFIA, -B, -C and -X, respectively) than in the background of the wild-type construct ␣6-181 (11-, 8-, 7-, and -6-fold repression with NFIA, -B, -C and -X, respectively) indicating that somehow, binding of Sp1 to the ␣6 promoter may attenuate repression by NFI even though neither is competing with the other for their respective target sites. . Formation of the DNA-protein complexes was then examined by EMSA as in Figure 4 . P, labeled probe alone.
DISCUSSION
Corneal wound healing is a process that requires complex cellular interactions between the cell surface integrin receptors and the ECM to achieve efficient cell migration and differentiation. Although FN deposition can be observed as early as 3 hours after damage to the corneal epithelium, no LM can be seen beneath the leading edge of migrating epithelial cells until 24 hours after the injury. 56 FN has been shown to induce the attachment and migration of the basal epithelial cells that border the injured area and to influence the transcriptional activity of the gene encoding the integrin subunit ␣6, 57 ensuring early expression well before LM accumulates beneath the leading edge. The signal transduction pathway that is activated on binding of the ␣6 integrin to LM is thought to trigger regulatory signals distinct from those resulting from the binding of FN to its corresponding integrins. As FN expression diminishes, secretion of LM increases to reach maximal expression 1 week after corneal damage 5 by inducing HDs assembly via its ␣6␤4 interaction to enforce stable attachment of basal cells to the basal membrane. 58, 59 Evidently, HDs also need to be disassembled to allow initial cell migration and proliferation after damage to the cornea. Thus, LM is desired only at the end of the wound-healing process, to return the cells to a normal proliferative state and attachment to initiate wound closure. Repression of ␣6 expression contributes to this final step of the corneal repair process by both restricting proliferation and allowing attachment of the epithelium to the basal membrane. We previously demonstrated that LM reduces expression of ␣6 during wound healing by lowering the levels of the nuclear TFs Sp1 and Sp3, which are believed to act as strong activators of ␣6 gene expression during the initial FN-mediated migration/ proliferation step that chiefly characterize this process. 31 In this study, we demonstrated that LM also increases the level of the transcription factor NFI that in turn binds the ␣6 promoter to repress its transcription. The location of the NFI site nearby the promoter-proximal Sp1 site along with the opposite regulatory influences of these TFs suggest that both may prejudice each other once they are bound to their respective target site in the ␣6 promoter and that the Sp1/NFI ratio must be very critical in dictating whether expression of the ␣6 gene will be activated or repressed, a process that is highly dependent on the orchestrated changes in the remodeling of the ECM components (such as FN or LM) during wound healing.
Although the ␣6 promoter bears a DNA sequence slightly different from the known consensus NFI-binding site, it clearly allows for specific NFI-binding, which in turn acts as a strong repressor of transcription. Because there are four NFI isoforms and their functional activity is poorly understood, it is difficult to understand which NFI isoforms actually bind and repress the ␣6 promoter in vivo. Because their DNA-binding domain is highly conserved, it is safe to state that any of these four isoforms possesses the capability to bind the ␣6 promoter. As NFI function is highly influenced by interaction with coactivators (no corepressor has been reported yet to interact with NFI) via their various catalytic domains, 60 -64 more extended studies are necessary to understand whether any particular NFI isoform is favored in the various cellular requirements. One interesting hypothesis is that each isoform exists only to act as a redundant fail-safe factor to ensure accomplishment of key cellular functions. Because NFI has been shown to act as a critical repressor of p21 (CDKN1A) gene expression during cell cycle and senescence, 38 it is possible that genomic evolution favors such redundancy to maintain critical housekeeping gene regulation. In our model, RNAi and overexpression experiments showed that each of the four isoforms could function as a strong repressor of ␣6 transcription in HCECs grown over LM, which would give support to this hypothesis.
Since NFI and Sp1 nuclear levels vary inversely to one another when cells are grown on LM, we can hypothesize that regulation of ␣6 is mediated most probably by overall expression of these factors and their cellular availability and less likely by posttranslational modifications that may alter their binding properties or their structural integrity. Previous reports demonstrated O-glycosylation 65 and phosphorylation 37, 66 of NFI A.
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peptides. Indeed, posttranslational modifications such as glycosylation, have been reported to stimulate DNA binding of NFIB 67 in the transcriptional activation of the whey acidic protein (WAP) gene. Similarly, N-glycosylation of NFIC has been postulated to improve its potential to recruit coactivators, corepressors, or other nuclear regulatory targets in the transcriptional activity directed by the mouse clustering promoter. 68 Of particular interest, phosphorylation of NFIC by Jak2 has been shown to restrain this TF from proteasomal degradation. 69 Although these modifications cannot be excluded, the clear influence of LM in both increasing NFI levels (and by way of consequence, its availability) and altering its electrophoretic mobility in EMSA are most likely the keys to ␣6 repression under such a physiological condition. Considering the growing interest given to microRNAs (miRNA) in gene suppression and the fact that NFI-A is a target of two such miRNAs, for instance miR-223 and miR-424, 70, 71 an investigate into that extent that LM alters the expression of these miRNAs in relation to ␣6 gene expression would surely be interesting.
Although the EMSA provided evidence that both Sp1 and NFI can bind simultaneously to their respective target sites in the ␣6 promoter, transfection analysis also suggested that Sp1 may restrict the negative regulatory influence of NFI, as mutation of the Sp1 site translated into a deeper repression by NFI. Direct interaction between NFIX and Sp1, which blocks the transactivating properties of the latter TF and results in the repression of PDGF-B gene transcription, has been recently documented and shown to be dependent on residues 243-416 from NFIX. 43 This raises the interesting possibility that subtle alterations in the Sp1-to-NFI ratio dictate whether transcription of the ␣6 gene should be enhanced or suppressed in cultured cells.
Of interest, NFIA was the only isoform that remained unaffected in the RNAi experiment, although overexpression of the NFIA cDNA resulted in a high repressive action similar to that achieved with the other NFI isoforms. Besides, NFIA was the least expressed of all four NFI transcripts when the cells were grown without LM, whereas it was transcribed to the highest level in the presence of LM. This finding suggests that initial low mRNA levels do not show much reactivity to RNAi, but when overexpressed, the repressive action of NFIA over the ␣6 promoter then becomes significant. One must keep in mind that overexpression experiments bring large amounts of transcripts that would not normally be observed in an in vivo environment. This raises the possibility that NFIA may not be the favored isoform in binding the ␣6 promoter in vivo, which would also justify the RNAi results observed.
In summary, we demonstrated that binding of NFI to the basal promoter of the human ␣6 gene strongly represses its 
